Pulmatrix (PULM) Times Interest Earned (2014 - 2026)
Pulmatrix (PULM) posted Times Interest Earned of -$25.84 for Q1 2026, down 79153.1% sequentially from -$0.03 in Q4 2025, and up 56.63% YoY from -$16.5 in Q1 2025.
Pulmatrix (PULM) Times Interest Earned (2014 - 2026) Analysis & Trends
Pulmatrix has reported Times Interest Earned for 13 years, with the latest figure at -$25.84 in Q1 2026.
- Quarterly Times Interest Earned rose 56.63% year-over-year to -$25.84 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$92.28 (up 76.85% YoY) and the FY2025 annual result came in at -$0.19, up 98.71% from the prior year.
- Times Interest Earned eased to -$25.84 in Q1 2026 per PULM's latest filing, from -$0.03 in the prior quarter.
- Over five years, Times Interest Earned peaked at $20.6 in Q4 2023 and troughed at -$110.71 in Q3 2024.
- A 5-year average of -$25.0 and a median of -$13.32 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned surged 305.78% in 2023, then slumped 113622.27% in 2025.
- Over 5 years, Times Interest Earned stood at -$10.01 in 2022, then jumped by 305.78% to $20.6 in 2023, then sank by 637.37% to -$110.71 in 2024, then soared by 99.97% to -$0.03 in 2025, then plunged by 79153.1% to -$25.84 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$25.84, -$0.03, and -$86.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.92 |
| Mar 31, 2026 | -25.84 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -86.60 |
| Jun 30, 2025 | -45.53 |
| Mar 31, 2025 | -59.58 |
| Sep 30, 2024 | -110.71 |
| Jun 30, 2024 | -18.33 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 20.60 |
| Sep 30, 2023 | -1.46 |
| Jun 30, 2023 | -9.24 |
| Mar 31, 2023 | -10.64 |
| Dec 31, 2022 | -10.01 |
| Sep 30, 2022 | -11.83 |
| Jun 30, 2022 | -14.80 |
| Mar 31, 2022 | -16.11 |
| Dec 31, 2021 | -13.57 |
| Sep 30, 2021 | -27.39 |
| Jun 30, 2021 | -12.87 |